Click image to view full size image
Throughout the world, EECP/ECP therapy has been studied for various potential uses other than heart disease (48–53) (Table 3). Its role in improving endothelial function might be beneficial in the treatment of patients with Cardiac Syndrome X, which is marked by severe chest pain caused by myocardial dysfunction, often without detectable atherosclerosis. Mayo Clinic investigators have reported successful treatment of Cardiac Syndrome X with severely symptomatic coronary endothelial dysfunction in the absence of obstructive CAD with standard 35-h course of EECP therapy (54). However, it is important to realize that EECP therapy is an option for patients with angina refractory to medical treatment who are not candidates for interventional or surgical revascularization
Product Dimensions and Weight （P-ECP/TI）
Physical dimensions: length × width × height = 2070mm × 1120mm × 1100mm
Net weight: 220kg
Gross weight: 300kg
Cuffs and Bladders
Six sizes fit all patients' types: XS, S, M, L, XL, XXL
Calf, upper thigh, buttocks are integrated
Backrest of the bed
Adjustable angle range: 0°~38°
Safe working load: 105KG
Remote control adjustable
Other
Treatment time setting range: 1min~60min
Solenoid valve response time: ≤50ms
Noise: ≤67dB
http://www.cneecp.com/